E. Puighermanal, A. Busquets-garcia, R. Maldonado, and A. Ozaita, Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids, Philos Trans R Soc Lond B Biol Sci, vol.367, pp.3254-3263, 2012.

C. Castellano, C. Rossi-arnaud, V. Cestari, and M. Costanzi, Cannabinoids and memory: animal studies, Curr Drug Targets CNS Neurol Disord, vol.2, p.14683467, 2003.

F. Rodríguez-de-fonseca, P. Rubio, F. Menzaghi, E. Merlo-pich, J. Rivier et al., Corticotropinreleasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats, J Pharmacol Exp Ther, vol.276, p.8558457, 1996.

F. A. Moreira and B. Lutz, The endocannabinoid system: emotion, learning and addiction, Addict Biol, vol.13, pp.196-212, 2008.

R. Maldonado, F. Berrendero, A. Ozaita, and P. Robledo, Neurochemical basis of cannabis addiction. Neuroscience, vol.181, p.21334423, 2011.

J. M. Walker and A. G. Hohmann, Cannabinoid mechanisms of pain suppression, Handb Exp Pharmacol, vol.PMID, p.16596786, 2005.

E. Valjent, J. M. Mitchell, M. Besson, J. Caboche, and R. Maldonado, Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine, Br J Pharmacol, vol.135, p.11815392, 2002.

J. F. Cheer, A. K. Cadogan, C. A. Marsden, K. C. Fone, and D. A. Kendall, Modification of 5-HT2 receptor mediated behavior in the rat by oleamide and the role of cannabinoid receptors, Neuropharmacology, vol.38, p.10221757, 1999.

N. A. Darmani, Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice, Pharmacol Biochem Behav, vol.68, p.11267636, 2001.

B. B. Gorzalka, M. N. Hill, and J. C. Sun, Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes, Eur J Pharmacol, vol.516, p.15913602, 2005.

E. Aso, T. Renoir, G. Mengod, C. Ledent, M. Hamon et al., Lack of CB1 receptor activity impairs serotonergic negative feedback, J Neurochem, vol.109, pp.935-944, 2009.

S. Mato, E. Aso, E. Castro, M. Martín, O. Valverde et al., CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors, J Neurochem, vol.103, p.17944876, 2007.

J. C. Parrish and D. E. Nichols, Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism, J Neurochem, vol.99, p.17010161, 2006.

A. R. Best and W. G. Regehr, Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses, J Neurosci Off J Soc Neurosci, vol.28, pp.6508-6515, 2008.

R. Mechoulam and L. A. Parker, The endocannabinoid system and the brain, Annu Rev Psychol, vol.64, pp.21-47, 2013.

C. Bombardi, D. Giovanni, and G. , Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions, Exp Brain Res, vol.230, pp.427-439, 2013.

J. De-almeida and G. Mengod, Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex, J Neurochem, vol.103, p.17635672, 2007.

K. Tsou, S. Brown, M. C. Sañudo-peña, K. Mackie, and J. M. Walker, Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system, Neuroscience, vol.83, p.9460749, 1998.

A. L. Bodor, I. Katona, G. Nyíri, K. Mackie, C. Ledent et al., Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types, J Neurosci Off J Soc Neurosci, vol.25, pp.6845-6856, 2005.

S. M. Eggan and D. A. Lewis, Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis, Cereb Cortex N Y N, vol.17, pp.175-191, 1991.

K. Tsou, K. Mackie, M. C. Sañudo-peña, and J. M. Walker, Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience, vol.93, p.10473261, 1999.

R. L. Jakab and P. S. Goldman-rakic, 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites, Proc Natl Acad Sci U S A, vol.95, p.9435262, 1998.

. Miner-l-a.-h, J. R. Backstrom, E. Sanders-bush, and S. R. Sesack, Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex, Neuroscience, vol.116, p.12535944, 2003.

J. J. Rodriguez, K. Mackie, and V. M. Pickel, Ultrastructural localization of the CB1 cannabinoid receptor in muopioid receptor patches of the rat Caudate putamen nucleus, J Neurosci Off J Soc Neurosci, vol.21, pp.823-833, 2001.

A. Pazos, R. Cortés, and J. M. Palacios, Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors, Brain Res, vol.346, p.4052777, 1985.

G. Mengod, M. Pompeiano, M. I. Martínez-mir, and J. M. Palacios, Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites, Brain Res, vol.524, p.2400925, 1990.

E. T. Weber and R. Andrade, Htr2a Gene and 5-HT(2A) Receptor Expression in the Cerebral Cortex Studied Using Genetically Modified Mice, Front Neurosci, vol.4, p.36, 2010.

H. Y. Meltzer, S. Matsubara, and J. C. Lee, Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values, J Pharmacol Exp Ther, vol.251, p.2571717, 1989.

J. González-maeso, N. V. Weisstaub, M. Zhou, P. Chan, L. Ivic et al., Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior, Neuron, vol.53, p.17270739, 2007.

M. Schneider and M. Koch, Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, vol.28, pp.1760-1769, 2003.

K. A. Gleason, S. G. Birnbaum, A. Shukla, and S. Ghose, Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia, Transl Psychiatry, vol.2, p.199, 2012.

F. Berrendero and R. Maldonado, Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol, Psychopharmacology (Berl), vol.163, pp.111-117, 2002.

L. P. Martin, D. M. Jackson, C. Wallsten, and B. L. Waszczak, Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing, J Pharmacol Exp Ther, vol.288, p.9918594, 1999.

M. J. Orejarena, L. Lanfumey, R. Maldonado, and P. Robledo, Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behavior, Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacol CINP, vol.14, pp.927-940, 2011.

J. R. Clapper, R. A. Mangieri, and D. Piomelli, The endocannabinoid system as a target for the treatment of cannabis dependence, Neuropharmacology, vol.56, issue.1, pp.235-243, 2009.

V. Mendizábal, A. Zimmer, and R. Maldonado, Involvement of kappa/dynorphin system in WIN 55,212-2 selfadministration in mice, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, vol.31, pp.1957-1966, 2006.

, Sanchis-Segura C, Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview, CB 1 R-5-HT 2A R Heteromers Mediate THC-Induced Cognitive Deficits PLOS Biology, vol.37, p.16759333, 2006.

R. Schroder, J. Schmidt, S. Blattermann, L. Peters, N. Janssen et al., Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells, Nat Protoc, vol.6, p.22015845, 2011.

L. J. Sim-selley, Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids, Crit Rev Neurobiol, vol.15, p.14977366, 2003.

S. Ferré, V. Casadó, L. A. Devi, M. Filizola, R. Jockers et al., Protein-Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives, Pharmacol Rev, vol.66, p.24515647, 2014.

S. Ferré, The GPCR heterotetramer: challenging classical pharmacology, Trends Pharmacol Sci, vol.36, pp.145-152, 2015.

M. Bouvier, N. Heveker, R. Jockers, S. Marullo, and G. Milligan, BRET analysis of GPCR oligomerization: newer does not mean better, Nat Meth, vol.4, pp.3-4, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00119759

T. Issad and R. Jockers, Bioluminescence Resonance Energy Transfer to Monitor Protein-Protein Interactions. Transmembrane Signaling Protocols, pp.193-210
DOI : 10.1385/1-59745-048-0:193

O. Söderberg, K. Leuchowius, M. Gullberg, M. Jarvius, I. Weibrecht et al., Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay, Methods San Diego Calif, vol.45, pp.227-232, 2008.

M. Mocanu, T. Váradi, J. Szöll?si, and P. Nagy, Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA), PROTEOMICS, vol.11, pp.2063-2070, 2011.
DOI : 10.1002/pmic.201100028

K. Baba, A. Benleulmi-chaachoua, A. Journe, M. Kamal, J. Guillaume et al., Heteromeric MT1/MT2 Melatonin Receptors Modulate Photoreceptor Function, Sci Signal, vol.6, p.89, 2013.
DOI : 10.1126/scisignal.2004302

URL : http://europepmc.org/articles/pmc3867265?pdf=render

S. González, D. Moreno-delgado, E. Moreno, K. Pérez-capote, R. Franco et al., CircadianRelated Heteromerization of Adrenergic and Dopamine D4 Receptors Modulates Melatonin Synthesis and Release in the Pineal Gland, PLoS Biol, vol.10, p.22723743, 2012.

A. Kern, R. Albarran-zeckler, H. E. Walsh, and R. G. Smith, Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 Agonism, Neuron, vol.73, p.22284186, 2012.

E. Moreno, S. H. Vaz, N. Cai, C. Ferrada, C. Quiroz et al., Dopamine-Galanin Receptor Heteromers Modulate Cholinergic Neurotransmission in the Rat Ventral Hippocampus, J Neurosci Off J Soc Neurosci, vol.31, pp.7412-7423, 2011.

E. Moreno, D. Moreno-delgado, G. Navarro, H. M. Hoffmann, S. Fuentes et al., Cocaine Disrupts Histamine H3 Receptor Modulation of Dopamine D1 Receptor Signaling: ?1-D1-H3 Receptor Complexes as Key Targets for Reducing Cocaine's Effects, J Neurosci Off J Soc Neurosci, vol.34, pp.3545-3558, 2014.

A. J. Venkatakrishnan, X. Deupi, G. Lebon, C. G. Tate, G. F. Schertler et al., Molecular signatures of G-protein-coupled receptors, Nature, vol.494, pp.185-194, 2013.

S. Rasmussen, B. T. Devree, Y. Zou, A. C. Kruse, K. Y. Chung et al., Crystal structure of the ?2 adrenergic receptor-Gs protein complex, Nature, vol.477, pp.549-555, 2011.

S. Rasmussen, H. Choi, J. J. Fung, E. Pardon, P. Casarosa et al., Structure of a nanobodystabilized active state of the ?(2) adrenoceptor, Nature, vol.469, pp.175-180, 2011.

A. Manglik, A. C. Kruse, T. S. Kobilka, F. S. Thian, J. M. Mathiesen et al., Crystal structure of the ?-opioid receptor bound to a morphinan antagonist, Nature, vol.485, pp.321-326, 2012.

X. Guitart, G. Navarro, E. Moreno, H. Yano, N. Cai et al., Functional Selectivity of Allosteric Interactions within GPCR oligomers: the Dopamine D1-D3 Receptor Heterotetramer, Mol Pharmacol, 2014.

L. Lee, S. Ng, J. Chu, R. Sekar, K. G. Harikumar et al., Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex, FASEB J, pp.13-246868, 2014.

S. Ferre, R. Baler, M. Bouvier, M. G. Caron, L. A. Devi et al., Building a new conceptual framework for receptor heteromers, Nat Chem Biol, vol.5, pp.131-134, 2009.

A. C. Magalhaes, K. D. Holmes, L. B. Dale, L. Comps-agrar, D. Lee et al., CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling, Nat Neurosci, vol.13, p.20383137, 2010.

M. Lüttgen, O. Ogren, S. Meister, and B. , Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus, Brain Res, vol.1010, p.15126129, 2004.

J. M. Franklin, M. Mathew, and G. A. Carrasco, Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats, Neurosci Lett, vol.548, p.23721787, 2013.

N. V. Weisstaub, M. Zhou, A. Lira, E. Lambe, J. González-maeso et al., Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice, Science, vol.313, p.16873667, 2006.

G. Porras, D. Matteo, V. Fracasso, C. Lucas, G. De-deurwaerdère et al., 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, vol.26, pp.311-324, 2002.

J. F. López-giménez, G. Mengod, J. M. Palacios, and M. T. Vilaró, Selective visualization of rat brain 5-HT2A receptors by autoradiography with, Naunyn Schmiedebergs Arch Pharmacol, vol.907, p.9349630, 1997.

N. Kabli, T. Nguyen, G. Balboni, B. F. O'dowd, and S. R. George, Antidepressant-like and anxiolytic-like effects following activation of the ?-? opioid receptor heteromer in the nucleus accumbens, Mol Psychiatry, vol.19, p.24061495, 2014.

F. Steindel, R. Lerner, M. Häring, S. Ruehle, G. Marsicano et al., Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus, J Neurochem, vol.124, pp.795-807, 2013.

D. Chiara, G. Bassareo, V. Fenu, S. De-luca, M. A. Spina et al., Dopamine and drug addiction: the nucleus accumbens shell connection, Neuropharmacology, vol.47, issue.1, p.15464140, 2004.

Y. Chiang, Y. Lo, and J. Chen, Crosstalk between dopamine D 2 receptors and cannabinoid CB 1 receptors regulates CNR1 promoter activity via ERK1/2 signaling, J Neurochem, vol.127, p.23952963, 2013.

G. M. Thomas and R. L. Huganir, MAPK cascade signalling and synaptic plasticity, Nat Rev Neurosci, vol.5, p.14976517, 2004.

P. Rivera, S. Arrabal, M. Cifuentes, J. M. Grondona, M. Pérez-martín et al., Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGL?) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus, Front Neuroanat, vol.8, p.56, 2014.

J. F. López-giménez, M. T. Vilaró, J. M. Palacios, and G. Mengod, Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies, J Comp Neurol, vol.429, p.11135236, 2001.

R. Franco, E. Martínez-pinilla, A. Ricobaraza, and P. J. Mccormick, Challenges in the development of heteromer-GPCR-based drugs, Prog Mol Biol Transl Sci, vol.117, pp.143-162, 2013.

M. Fribourg, J. L. Moreno, T. Holloway, D. Provasi, L. Baki et al., Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs, Cell, vol.147, p.22118459, 2011.

R. Nygaard, Y. Zou, R. O. Dror, T. J. Mildorf, D. H. Arlow et al., The Dynamic Process of ?2-Adrenergic Receptor Activation, Cell, vol.152, pp.532-542, 2013.

P. Pacher and G. Kunos, Modulating the endocannabinoid system in human health and diseasesuccesses and failures, FEBS J, vol.280, p.23551849, 2013.

J. González-maeso, T. Yuen, B. J. Ebersole, E. Wurmbach, A. Lira et al., Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex, J Neurosci Off J Soc Neurosci, vol.23, pp.8836-8843, 2003.

E. Fiorica-howells, R. Hen, J. Gingrich, Z. Li, and M. D. Gershon, 5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice, Am J Physiol Gastrointest Liver Physiol, vol.282, p.11960784, 2002.

A. Zimmer, A. M. Zimmer, A. G. Hohmann, M. Herkenham, and T. I. Bonner, Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice, Proc Natl Acad Sci U S A, vol.96, p.10318961, 1999.

K. Monory, H. Blaudzun, F. Massa, N. Kaiser, T. Lemberger et al., Genetic dissection of behavioral and autonomic effects of Delta(9)-tetrahydrocannabinol in mice, PLoS Biol, vol.5, p.17927447, 2007.

E. Puighermanal, G. Marsicano, A. Busquets-garcia, B. Lutz, R. Maldonado et al., Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling, Nat Neurosci, vol.12, pp.1152-1158, 2009.

K. Mackie, Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength, Int J Obes, vol.30, issue.1, pp.19-23, 2005.

R. Mongeau, C. Martin, C. Chevarin, R. Maldonado, M. Hamon et al., 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment, J Neurochem, vol.115, p.20796171, 2010.

A. Pertovaara and A. Almeida, Chapter 13 Descending inhibitory systems, Handb Clin Neurol, vol.81, pp.179-192, 2006.

E. Palazzo, L. Luongo, V. Novellis, . De, F. Rossi et al., The Role of Cannabinoid Receptors in the Descending Modulation of Pain, Pharmaceuticals, vol.3, pp.2661-2673, 2010.

F. Simonin, O. Valverde, C. Smadja, S. Slowe, I. Kitchen et al., Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal, EMBO J, vol.17, p.9463367, 1998.

N. B. Eddy and D. Leimbach, Synthetic analgesics. II. Dithienylbutenyl-and dithienylbutylamines, J Pharmacol Exp Ther, vol.107, p.13035677, 1953.

G. Soria, V. Mendizábal, C. Touriño, P. Robledo, C. Ledent et al., Lack of CB1 cannabinoid receptor impairs cocaine self-administration, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, vol.30, pp.1670-1680, 2005.

A. Castañé, R. Maldonado, and O. Valverde, Role of different brain structures in the behavioral expression of WIN 55,212-2 withdrawal in mice, Br J Pharmacol, vol.142, p.15265804, 2004.

S. Pellow, P. Chopin, S. E. File, and M. Briley, Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J Neurosci Methods, vol.14, p.2864480, 1985.

C. P. Vandermaelen and G. K. Aghajanian, Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices, Brain Res, vol.289, p.6140982, 1983.

L. Lanfumey, M. C. Pardon, N. Laaris, C. Joubert, N. Hanoun et al., 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice, Neuroreport, vol.10, p.10599847, 1999.

S. Haj-dahmane, M. Hamon, and L. Lanfumey, K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study, Neuroscience, vol.41, p.1714550, 1991.

G. Paxinos and K. Franklin, The Mouse Brain in Stereotaxic Coordinates, 2004.

A. Busquets-garcia, E. Puighermanal, A. Pastor, R. De-la-torre, R. Maldonado et al., Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses, Biol Psychiatry, vol.70, pp.479-486, 2011.

C. Ferrada, E. Moreno, V. Casadó, G. Bongers, A. Cortés et al., Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors, Br J Pharmacol, vol.157, pp.64-75, 2009.

L. Callén, E. Moreno, P. Barroso-chinea, D. Moreno-delgado, A. Cortés et al., Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain, J Biol Chem, vol.287, pp.20851-20865, 2012.

E. Moreno, H. Hoffmann, M. Gonzalez-sepúlveda, G. Navarro, V. Casadó et al., Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway, J Biol Chem, vol.286, p.21173143, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00659407

T. Chen, T. J. Wardill, Y. Sun, S. R. Pulver, S. L. Renninger et al., Ultrasensitive fluorescent proteins for imaging neuronal activity, Nature, vol.499, pp.295-300, 2013.